This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Investigations

Authoring team

General markers of neuroendocrine tumours

  • chromogranin A (CgA)
    • a secretory granule, is located alongside specific hormones in large dense-core vesicles of neuronal and neuroendocrine cells
    • CgA is raised in 99% of metastatic carcinoid tumours
  • other general staining markers include pancreatic polypeptide, neuron-specific enolase, peptide histidine-methionine and human chorionic gonadotrophin subunits

Specific markers of carcinoid tumours

  • carcinoid tumours secrete a variety of catecholamines, including serotonin. Diagnosis can be made on the basis of a raised 24 hour urinary level of 5-HIAA - a breakdown product of serotonin; or by whole blood serotonin
    • other urinary markers include neuropeptide K, substance P and other tachykinins
    • urinary hydroxyindole acetic acid (5HIAA) and neuropeptide K show high sensitivity in midgut carcinoid - these markers have less diagnostic usefulness in foregut and hindgut carcinoid
  • if a diagnosis of carcinoid is suspected with normal baseline urinary testing, the pentagastrin test with measurements of plasma tachykinins is a useful diagnostic measure

Other investigations:

  • radiological localisation of carcinoid tumour
    • somatostatin-receptor-scintigraphy
      • sensitivity 90% and specificity 80%
    • CT
      • may be used preoperatively for localizing tumours- however difficulty detecting tumours <1cm
  • a liver ultrasound scan or CT scan may show evidence of secondaries in the liver.

Reference:

  1. Endocr Relat Cancer. 2004 Mar;11(1):1-18.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.